Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 150
  • Start Date: January 23, 2020
A First-in-Human, Open Label, Phase I/II Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patients With Advanced Tumors
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Behavioral
  • Participants: 170
  • Start Date: June 14, 2019
A Study to Identify the Supportive Care Needs of Caregivers of Patients With Erdheim-Chester Disease and Other Histiocytic Diseases
Search for trials
Clinical Trial
  • Status: Active, not recruiting
  • Participants: 1000
  • Start Date: August 20, 2018
Biomarker for Farber Disease - An International, Multicenter, Epidemiological Protocol
Clinical Trial
  • Status: Recruiting
  • Participants: 250
  • Start Date: October 26, 2017
Registry for Patients With Erdheim-Chester Disease
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 12
  • Start Date: August 2015
A Phase II Study of Lenalidomide for Adult Histiocyte Disorders
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 80
  • Start Date: October 2014
International Rare Histiocytic Disorders Registry (IRHDR)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug, Biological, Other
  • Participants: 216
  • Start Date: March 16, 2012
A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid, or Cetuximab in Patients With Advanced Malignancy and Other Indications
Showing 1-7 of 7